SCHEMBL21267673

SCHEMBL21267673

CC(C)c1cc(C(C)(C)C)n(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22693491 0.83 PDK2 (0.30)
SCHEMBL27114755 0.74 CYP1A2 (0.35)
SCHEMBL12342530 0.71 FABP3 (0.31)
SCHEMBL18698259 0.71 IDH1 (0.34)
SCHEMBL16704468 0.70
SCHEMBL15504790 0.69 GABRA1 (0.35)
SCHEMBL16418630 0.69 ALDH1A1 (0.32)
SCHEMBL21719387 0.67 MEN1 (0.31)
SCHEMBL21719378 0.67
SCHEMBL21718532 0.67 HDAC8 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322853-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PROLIFERATIVE DISEASES AND DISORDERS THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 2023-10-12 US disclosed
US-20230062022-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC (US) 2023-03-02 US disclosed
US-20190248774-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS SAGARD HOLDINGS MANAGER LP, AS ADMINISTRATIVE AGENT (CA) 2019-08-15 US disclosed